Detalhe da pesquisa
1.
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes.
Sci Transl Med
; 15(706): eabn4722, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494472
2.
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies.
Nat Med
; 27(11): 1970-1981, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675383
3.
The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer.
Clin Cancer Res
; 26(16): 4313-4325, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430479
4.
Foxp3+ T reg cells control psoriasiform inflammation by restraining an IFN-I-driven CD8+ T cell response.
J Exp Med
; 215(8): 1987-1998, 2018 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29980582
5.
Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis.
Nat Commun
; 9(1): 3797, 2018 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228258
6.
A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages.
Cell Host Microbe
; 22(6): 733-745.e5, 2017 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241040
7.
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Nat Med
; 23(5): 579-589, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28368383
8.
The human tissue-biomaterial interface: a role for PPARγ-dependent glucocorticoid receptor activation in regulating the CD163+ M2 macrophage phenotype.
Tissue Eng Part A
; 20(17-18): 2390-401, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24548290
9.
Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Nat Med
; 23(6): 788, 2017 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28586341